Dallas, TX (PRWEB) March 20, 2014 The Repair Stem Cells Institute (RSCI) -- http://www.repairstemcells.org -- is pleased to announce that it will assist interested patients to take part in a patient-sponsored research study based in the United States for the treatment of Type2 Diabetes with adult stem cells. The study, which meets current FDA guidelines, will be conducted during April 2014. The study is being conducted by the U.S. based company Bioheart which has assembled teams of doctors and specialists specially trained in stem cell treatments. Based on previous treatment of Type 2 diabetes with autologous (the patients own) stem cells, it is estimated that two-thirds of participants will experience a significant quality of life improvement and symptoms reduction. Type 2 diabetes makes up about 90% of cases of diabetes. Rates of type 2 diabetes have increased markedly since 1960. Today there are approximately 50 million people suffering from the disease compared to 15 million in 1985. In a recent interview, RSCI founder and Chairman Don Margolis stated, With stem cell treatment rapidly coming to the forefront of 21st Century medicine, we are pleased that Type 2 Diabetes is among the many chronic conditions that are treatable with adult stem … Continue reading →

PUBLIC RELEASE DATE: 20-Mar-2014 Contact: Tan Yun Yun tan_yun_yun@a-star.edu.sg 656-826-6273 Biomedical Sciences Institutes (BMSI) 1. Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have developed a method to generate human induced pluripotent stem cells (hiPSCs) from a single drop of finger-pricked blood. The method also enables donors to collect their own blood samples, which they can then send to a laboratory for further processing. The easy access to blood samples using the new technique could potentially boost the recruitment of greater numbers and diversities of donors, and could lead to the establishment of large-scale hiPSC banks. 2. By genetic reprogramming, matured human cells, usually blood cells, can be transformed into hiPSCs. As hiPSCs exhibit properties remarkably similar to human embryonic stem cells, they are invaluable resources for basic research, drug discovery and cell therapy. In countries like Japan, USA and UK , a number of hiPSC bank initiatives have sprung up to make hiPSCs available for stem cell research and medical studies. 3. Current sample collection for reprogramming into hiPSCs include invasive measures such as collecting cells from the bone marrow or skin, which may put off many potential donors. Although hiPSCs may also be generated from blood … Continue reading →

PUBLIC RELEASE DATE: 20-Mar-2014 Contact: Anne DeLotto Baier abaier@health.usf.edu 813-974-3303 University of South Florida (USF Innovation) Tampa, FL (Mar. 20, 2014) Traumatic brain injuries (TBI), sustained by close to 2 million Americans annually, including military personnel, are debilitating and devastating for patients and their families. Regardless of severity, those with TBI can suffer a range of motor, behavioral, intellectual and cognitive disabilities over the short or long term. Sadly, clinical treatments for TBI are few and largely ineffective. In an effort to find an effective therapy, neuroscientists at the Center of Excellence for Aging and Brain Repair, Department of Neurosurgery in the USF Health Morsani College of Medicine, University of South Florida, have conducted several preclinical studies aimed at finding combination therapies to improve TBI outcomes. In their study of several different therapiesalone and in combinationapplied to laboratory rats modeled with TBI, USF researchers found that a combination of human umbilical cord blood cells (hUBCs) and granulocyte colony stimulating factor (G-CSF), a growth factor, was more therapeutic than either administered alone, or each with saline, or saline alone. The study appeared in a recent issue of PLoS ONE. "Chronic TBI is typically associated with major secondary molecular injuries, including chronic … Continue reading →

What are the various methods of treating epilepsy? (Manoj Raghavan, MD, PhD) Manoj Raghavan, MD, PhD, neurologist, discusses epilepsy treatment and how the treatments differ based on the origin of the seizures. Dr. Raghavan is part of... By: Froedtert the Medical College of Wisconsin … Continue reading →

VANCOUVERGeneticistWendy Chungtook tothe TED stage on Wednesday to discuss one of todays most perplexing problems: the twenty-fold increase in autism diagnoses in children over the past three decades. What we know for certain (and what she made clear) is that vaccines are absolutely not to blame. There is no credible evidence to support the assertion that vaccination causes autism, and there is plenty of evidence to rule it out. Autism diagnoses are certainly on the rise, though; one in 88 children will be diagnosed with autism this year. But the rise of diagnoses does not necessarily mean that there has been a rise in autism. In fact, Chung does not believe that there has been a massive increase in autism cases. The vast majority of it is the increase in diagnoses, Chung said. Medical professionals are now far better trained to detect and diagnose autism, so it's diagnosed more often. At the same time, autism is not a single disorder. It's actually a spectrum of disorders, from the completely debilitating to milder cases that may only affect socialization or education. Theres also an important practical matter to consider: the passage of the Individuals with Disabilities Educational Act in 1990. This … Continue reading →

After a few minutes of debating with the Liberals during question period, Health Minister Susan Sullivan recited more statistics about autism treatment for children. Statistics dont diagnose kids, Liberal MHA Eddie Joyce shouted at her. Sullivan kept describing what the government is doing to deal with autism in children, and the Liberals kept insisting that whatever it is, its not working. In November 2013, there were 379 children on a wait list to be diagnosed with autism at the Janeway. Eastern Health said last week that the wait list is so long because there is too little staff and physician resources to meet the need, Liberal MHA Andrew Parsons said. Why havent the sufficient resources been provided by government to deal with these long wait lists? Sullivan said that a lot has, in fact, been done. Hes right that the numbers of children who are presenting with autism are growing, she said. So were working to meet those needs, and that is precisely why we have a 20 per cent increase in the number of physiotherapy positions, that we have a 30 per cent increase in the number of occupational therapy position, that we have a 29 per cent increase … Continue reading →

Shaving even a minute off the time between the onset of a stroke and initial treatment may add to the amount of "healthy" days people have afterward, suggests a new study. Researchers found that stroke patients gained about two days of healthy life for every minute spared between the onset of their stroke and when they first received treatment, on average. "Every 15 minutes you wait, you lose a month of life," Dr. Atte Meretoja told Reuters Health. Meretoja is the study's lead author from the Melbourne Brain Centre at the Royal Melbourne Hospital in Parkville, Australia. The exact ratio of saved treatment time to healthy days varied by patient, he and his team found. Although it's well known that early treatment for strokes is best, the new study helps highlight how significant even small delays can be, researchers said. "We developed that measure so it's easy to remember and that the general public will understand it," Meretoja said. He and his colleagues summarized their findings in the journal Stroke as, "Save a Minute, Save a Day." There is currently only one treatment approved by U.S. regulators for ischemic strokes, which are caused by blockages in blood vessels going to … Continue reading →

MELBOURNE, Australia Diane Barbeler had a stroke on a Monday this month. The next day, she walked out of the hospital with only minor sensory changes in her right hand and foot. Barbeler owes her quick recovery to the tissue plasminogen activator, or tPA, that she received within three hours of losing strength and control in her lower limb, says Atte Meretoja, a neurologist who helped diagnose her stroke at Australias Royal Melbourne Hospital. Patients like Barbeler, 66, gain a month of disability-free life for every 15 minutes saved in getting the clot-busting drug, according to research by Meretoja and colleagues published Friday in the journal Stroke. By quantifying the importance of speed, Meretoja and collaborators in Australia, Finland and the U.S. aim to inspire medical services to improve response time. The worlds fastest stroke services in Helsinki and Melbourne take an average of 20 minutes from the patients arrival at the hospital to start tPA treatment, Meretoja said. Most other centers in Australia, the U.S. and Europe take 70 to 80 minutes. The main delay in stroke is due to people not calling for help, said Meretoja, the lead author of the study and an associate professor of medicine … Continue reading →